Axitinib is used in the treatment of kidney cancer
How it works
In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Axitinib blocks this signal, and thus stops the production of these cancer cells.
Common side effects
Headache, Nausea, Rash, Breathing difficulty, Joint pain, Difficulty in speaking, Decreased level of thyroid hormones, Pain in extremity, Haemorrhage, Vomiting, Abdominal pain, Dyspepsia, Dry skin, Diarrhoea, Increased blood pressure, Decreased appetite, Cough, Altered taste, Hand-foot syndrome, Constipation, Stomatitis (Inflammation of the mouth), Protein in urine
- ₹79499Pfizer Ltd1 variant(s)
- Inform your doctor if you have gastrointestinal infection, ulcer, or undergone gastrointestinal surgeries.
- Discontinue the use of axitinib, 24 hours prior to a scheduled surgery.
- Your blood pressure, liver function and thyroid function will be monitored before and during axitinib treatment.
- Do not take this drug if you are allergic to Axitinib or any of its ingredients.
- Seek immediate medical attention if you suffer from bleeding problems, severe stomach pain that lasts longer, fits, changes in vision, excessive tiredness, swelling of the abdomen, legs or ankles, shortness of breath, or protruding neck veins.
Frequently asked questions
Q. Is axitinib approved by FDA?
Yes, axitinib is approved by FDA.